227 related articles for article (PubMed ID: 28402947)
61. Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer.
Xu L; Li X; Cai M; Chen J; Li X; Wu WK; Kang W; Tong J; To KF; Guan XY; Sung JJ; Chan FK; Yu J
Gut; 2016 Apr; 65(4):635-46. PubMed ID: 25947013
[TBL] [Abstract][Full Text] [Related]
62. Clinical and prognostic significance of Arl4c expression in colorectal cancer.
Chen X; Su Z; Wang S; Xu H
Cancer Biomark; 2016; 16(2):253-7. PubMed ID: 26756615
[TBL] [Abstract][Full Text] [Related]
63. Biological Characteristics and Clinical Significance of ITGB1 and RHOC in Patients With Recurrent Colorectal Cancer.
Ha YJ; Tak KH; Kim SK; Kim CW; Lee JL; Roh SA; Cho DH; Kim SY; Kim YS; Kim JC
Anticancer Res; 2019 Sep; 39(9):4853-4864. PubMed ID: 31519588
[TBL] [Abstract][Full Text] [Related]
64. MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.
Vishnubalaji R; Hamam R; Yue S; Al-Obeed O; Kassem M; Liu FF; Aldahmash A; Alajez NM
Oncotarget; 2016 Jun; 7(24):35789-35802. PubMed ID: 27119506
[TBL] [Abstract][Full Text] [Related]
65. Characterization of SLC22A18 as a tumor suppressor and novel biomarker in colorectal cancer.
Jung Y; Jun Y; Lee HY; Kim S; Jung Y; Keum J; Lee YS; Cho YB; Lee S; Kim J
Oncotarget; 2015 Sep; 6(28):25368-80. PubMed ID: 26196590
[TBL] [Abstract][Full Text] [Related]
66. Thyroid hormone receptor β1 suppresses proliferation and migration by inhibiting PI3K/Akt signaling in human colorectal cancer cells.
Zhu L; Tian G; Yang Q; De G; Zhang Z; Wang Y; Nie H; Zhang Y; Yang X; Li J
Oncol Rep; 2016 Sep; 36(3):1419-26. PubMed ID: 27431682
[TBL] [Abstract][Full Text] [Related]
67. CHIP/Stub1 functions as a tumor suppressor and represses NF-κB-mediated signaling in colorectal cancer.
Wang Y; Ren F; Wang Y; Feng Y; Wang D; Jia B; Qiu Y; Wang S; Yu J; Sung JJ; Xu J; Zeps N; Chang Z
Carcinogenesis; 2014 May; 35(5):983-91. PubMed ID: 24302614
[TBL] [Abstract][Full Text] [Related]
68. High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers.
Yu J; Li X; Zhong C; Li D; Zhai X; Hu W; Guo C; Yuan Y; Zheng S
Oncotarget; 2016 Nov; 7(46):75279-75292. PubMed ID: 27661117
[TBL] [Abstract][Full Text] [Related]
69. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188
[TBL] [Abstract][Full Text] [Related]
70. Cytotoxic activity of the twigs of Cinnamomum cassia through the suppression of cell proliferation and the induction of apoptosis in human colorectal cancer cells.
Park GH; Song HM; Park SB; Son HJ; Um Y; Kim HS; Jeong JB
BMC Complement Altern Med; 2018 Jan; 18(1):28. PubMed ID: 29554905
[TBL] [Abstract][Full Text] [Related]
71. Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non-Small Cell Lung Carcinoma Cells.
Bar J; Hasim MS; Baghai T; Niknejad N; Perkins TJ; Stewart DJ; Sekhon HS; Villeneuve PJ; Dimitroulakos J
Neoplasia; 2016 Sep; 18(9):525-35. PubMed ID: 27659012
[TBL] [Abstract][Full Text] [Related]
72. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
73. Differential expression of alternatively spliced transcripts related to energy metabolism in colorectal cancer.
Snezhkina AV; Krasnov GS; Zaretsky AR; Zhavoronkov A; Nyushko KM; Moskalev AA; Karpova IY; Afremova AI; Lipatova AV; Kochetkov DV; Fedorova MS; Volchenko NN; Sadritdinova AF; Melnikova NV; Sidorov DV; Popov AY; Kalinin DV; Kaprin AD; Alekseev BY; Dmitriev AA; Kudryavtseva AV
BMC Genomics; 2016 Dec; 17(Suppl 14):1011. PubMed ID: 28105922
[TBL] [Abstract][Full Text] [Related]
74. GATA6 predicts prognosis and hepatic metastasis of colorectal cancer.
Shen F; Li J; Cai W; Zhu G; Gu W; Jia L; Xu B
Oncol Rep; 2013 Sep; 30(3):1355-61. PubMed ID: 23784465
[TBL] [Abstract][Full Text] [Related]
75. Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis.
Yuan Z; Yu X; Ni B; Chen D; Yang Z; Huang J; Wang J; Chen D; Wang L
Int J Oncol; 2016 Jun; 48(6):2675-85. PubMed ID: 27035092
[TBL] [Abstract][Full Text] [Related]
76. Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO.
Yang P; Chen T; Xu Z; Zhu H; Wang J; He Z
Oncotarget; 2016 Jul; 7(27):42183-42194. PubMed ID: 27259250
[TBL] [Abstract][Full Text] [Related]
77. Tumorigenesis and tumor progression related gene expression profiles in colorectal cancer.
Huang MY; Chen HC; Yang IP; Tsai HL; Wang TN; Juo SH; Wang JY
Cancer Biomark; 2013; 13(4):269-79. PubMed ID: 24240588
[TBL] [Abstract][Full Text] [Related]
78. Gab2 is a novel prognostic factor for colorectal cancer patients.
Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
[TBL] [Abstract][Full Text] [Related]
79. Solute carrier organic anion transporter family member 4A1 (SLCO4A1) as a prognosis marker of colorectal cancer.
Ban MJ; Ji SH; Lee CK; Bae SB; Kim HJ; Ahn TS; Lee MS; Baek MJ; Jeong D
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1437-1447. PubMed ID: 28378090
[TBL] [Abstract][Full Text] [Related]
80. Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression Signature Associated with Colorectal Cancer Distant Recurrence.
Alajez NM
PLoS One; 2016; 11(12):e0167455. PubMed ID: 27935967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
